Objective: To (1) compare clinic-level uninsured, Medicaid-insured, and privately insured visit rates within and between expansion and nonexpansion states before and after the Affordable Care Act (ACA) Medicaid expansion among the 3 cohorts of patient populations; and (2) assess whether there was a change in clinic-level overall, primary care visits, preventive care visits, and diabetes screening rates in expansion versus nonexpansion states from pre-ACA to post-ACA Medicaid expansion.
task for patients without continuous health insurance coverage. In addition, patients without health insurance are more likely to have undiagnosed diabetes and receive fewer preventive services overall than those with coverage. 2 Uninsured patients are also less likely to receive recommended diabetes screening and care and have poorer diabetes control than those with insurance. [3] [4] [5] [6] [7] [8] [9] [10] [11] Thus, both health insurance and continued access to health care services are essential for optimal diabetes prevention, care, and management. 2 The Patient Protection and Affordable Care Act (ACA) reform substantially improved access to health insurance and health care services for patients, especially among low-income adults. [12] [13] [14] [15] With the goal of covering all low-income US citizens and legal residents, 16 the ACA mandated health insurance coverage, called for the expansion of Medicaid to adults earning Յ138% of the federal poverty level (FPL), and provided subsidies to those making between 100% and 400% FPL to help purchase individual health insurance. Following the Supreme court ruling allowing states to choose whether or not to expand Medicaid, 32 states (and the District of Columbia) implemented expansions and 18 states did not (as of January 2018). 17 This "natural experiment" presents a unique opportunity to learn whether and to what extent Medicaid expansion can affect health care access and services for low-income patients with diabetes.
Many low-income adults in the United States receive care from community health centers (CHCs). CHCs provide health care to over 25 million people across America, regardless of patients' insurance status and offer sliding scale fees and low-income discounts to assist with cost. 18 Despite this discounted care, significant cost barriers still exist for uninsured patients. For example, one study estimated the average mean price for a CHC office visit for an uninsured patient was $89. 19 These financial barriers likely contribute to lower rates of preventive services, specialty care, and diagnostic procedures among uninsured compared with insured CHC patients. 3, 11, 20, 21 In fact, CHC visit patterns and services received at visits are different among patients with and without health insurance. 22 Following ACA implementation, CHCs saw a sharp rise in Medicaid-paid visits and a decrease in uninsured visits, 23, 24 most notably in expansion states. In addition, CHCs continue to accept new patients with Medicaid coverage, which is not the case for other primary care providers. 25, 26 This longitudinal, 4-year study used electronic health record (EHR) data from CHCs in 13 states (9 expansion states, 4 nonexpansion states) to compare changes in payer mix and primary care visit rates in expansion and nonexpansion states among 3 cohorts of patient populations, those with diabetes, prediabetes, and no diabetes. Specifically, we (1) compared clinic-level uninsured, Medicaid-insured, and privately insured visit rates within and between expansion and nonexpansion states before and after the ACA Medicaid expansion among 3 cohorts of patient populations; and (2) assessed whether there was a change in clinic-level total, primary care, and preventive care visits and diabetes screening rates in expansion versus nonexpansion states from pre-ACA to post-ACA Medicaid expansion. We hypothesized that CHCs in expansion states would see an increase in insured visits and overall visits among all 3 patient populations but expected the greatest increase to be among those with diabetes, as they have ongoing disease management needs. We also hypothesized that in nonexpansion states, CHC patient populations would experience a growth in insured visits and overall visits, but the increase would be smaller than in expansion states due to private health insurance cost sharing. These results will describe population-level changes in the type of payment CHCs received and health care services CHCs provided following the ACA Medicaid expansion and whether these changes were different among the 3 population cohorts.
Methods

Data Source
EHR data were obtained from the Accelerating Data Value Across a National Community Health Center Network (ADVANCE) clinical data research network (CDRN) of PCORNnet. 27 The ADVANCE CDRN is a unique "community laboratory" for research with underrepresented populations receiving care in CHCs. The 4-year study period included 2-years pre-ACA (1/1/2012 to 12/ 31/2013) and 2-years post-ACA (1/1/2014 to 12/ 31/2015) Medicaid expansion. Data for Ͼ5 million ambulatory visits were collected for 872,378 nonpregnant patients aged 19 to 64 years, with Ն1 ambulatory visit between 1/1/2012 and 12/31/2015 (n ϭ 483,912 in expansion states, n ϭ 388,466 in nonexpansion states) from 198 primary care CHCs "live" on their EHR system as of 1/1/2012 (n ϭ 131 CHCs in expansion states, n ϭ 67 CHCs in nonexpansion states).
Data Quality
EHR data contain information on payer types as well as billable codes for services performed at each visit; as these data are used for billing purposes, they represent reliable information on insurance status and services received at each visit, overcoming the limitations of recall bias and potential misinformation from survey respondents who may be confused regarding their insurance coverage status, especially given the complexity of the US health insurance system. In addition, CHCs are required to collect and report many individual-level demographic data variables to the US Health Resources and Services Administration to receive funding or designation under the Health Center Program. Therefore, EHR data from CHCs contain selfreported data on race/ethnicity, language, and FPL on nearly all patients.
Definitions of Population Cohorts
We used a validated computable phenotype to identify the patient population with diabetes. 28 -32 Those in the diabetes cohort had any combination of 2 diabetes-relevant "events," which included outpatient International Classification of Disease-9 or 10 diabetes-relevant diagnoses code(s), diagnostic-level laboratory results [1 glycohemoglobin (HbA1c) or glucose test meeting criteria for diabetes], and/or an order for antihyperglycemic agents no more than 730 days apart. 28 -32 Patient populations who had only 1 diabetes-relevant event were considered unconfirmed diabetes and were included in the prediabetes cohort. Patients were also included in the prediabetes cohort if they had at least 1 HbA1c result between 5.7% to 6.4% and/or a fasting glucose between 100 mg/ deciliter to 125 mg/deciliter, and no diabetes-relevant events. All others were included in the population cohort of patients without diabetes (referred to as no diabetes). Because the objective of this study was to assess changes in CHC population coverage and patterns in total, primary care, and preventive care visits and diabetes screening rates, we included patients diagnosed with diabetes and prediabetes at any time during the entire study period (pre-ACA or post-ACA). Most prediabetes (95%) and diabetes (68%) patients received a diagnosis before 2014. 
Medicaid Expansion Status
Insurance Coverage
For this visit-based study, we determined patient insurance status at the time of care receipt and knew how insurance status differed from visit to visit. These visit-level data were aggregated to the CHC level to estimate insurance mix pre-ACA and post-ACA and provide information on how the insurance visit mix changed overall between expansion and nonexpansion CHCs. Visit coverage was based on the primary payer listed for each visit and grouped as Medicaid, private, uninsured, or other public. Other public included (1) Medicare (for disability-eligible patients, as our patient population was under age 65); and, (2) grant programs that cover specific services such as breast and cervical cancer screening, family planning, and HIV/AIDS care. In CHCs, most private insurance is directly purchased as opposed to employer-sponsored coverage. CHCs serve patient populations who are predominantly low-income (71% with FPL below 100%), and national CHC data show that less than 30% of adults with Ͻ100% FPL have employersponsored coverage. 18 In addition, Census data
show that while direct-purchase insurance increased by 29% nationwide post-ACA, employersponsored insurance changed by Ͻ1%. 33 Therefore, any changes in private insurance visit rates in CHC likely reflect an increase in direct-purchase insurance.
Health Care Services
Health care use included total visits (rates of all billable encounters), primary care visits (all primary care, new patient, and established patient visits), and receipt of preventive care services. New patient visits included those who had not received services in the past 3 years, following the Current Procedural Terminology. Established patients with new types of insurance coverage were not considered new patients. Preventive care visits indicated nonproblem-focused encounters for general wellness and prevention (eg, annual exams and physicals). Visit types were determined using the primary Current Procedural Terminology code for each visit and primary care provider type. Diabetes screening included both HbA1c and fasting glucose testing.
Analysis
We summarized the demographic characteristics of CHC patient populations in expansion and nonexpansion states stratified by population cohort. We estimated clinic-level insurance types (uninsured, Medicaid, private, and other public); total, primary care, and preventive care visit rates; and diabetes screening in both the pre-ACA and post-ACA periods, stratified by diabetes status (diabetes, prediabetes, and no diabetes). We computed visit rates by dividing the number of visits in a given interval (ie, pre-ACA or post-ACA period) by the total number of adult patients seen in a clinic over the study period, scaled to 1000 patients per month. We estimated post-expansion versus pre-expansion rate ratios (RR) within each expansion group and difference-in-difference ratios (comparing prepost changes in rates between expansion groups) with 95% CIs by fitting generalized estimating equation Poisson models with robust sandwich variance estimators for each outcome. We clustered all models by CHC and used an exchangeable covariance structure to account for within-clinic temporal correlation for each diabetes status level. We produced unadjusted and adjusted estimates of RR and difference-in-difference ratios. In all adjusted models, we included the following covariates associated with differences in health insurance status 23, 24 : sociodemographic variables (clinic-level distributions of sex, age, race/ethnicity, and FPL), urban versus rural clinic location, and state-level factors (type of health insurance marketplace [state-run or federally facilitated], 2013 minimum wage, 2013 uninsured rate, 2013 unemployment rate, and prevalence of diabetes among CHC patients in 2013). Of note, there was no evidence of multicollinearity between the 2013 uninsured rate and 2013 unemployment rate (correlation, Ͻ0.5). We conducted a sensitivity analysis excluding the state-level variables from models; results were not altered (see Appendix). Analyses were conducted using R version 3.4.0, and statistical significance was set at type I error of 5%. This study was approved by the institutional review board. Table 1 describes the patient population and facility characteristics by expansion and diabetes status. The distribution of patient characteristics across the 3 population cohorts was similar in expansion and nonexpansion states. A greater proportion of the population with diabetes were male and older (40 to 64 years of age), relative to those with prediabetes or no diabetes. Notably, a large proportion of the patient population in nonexpansion states and expansion states had incomes Յ138% FPL (the expanded Medicaid eligibility criteria). In both expansion and nonexpansion states, CHCs saw an increase in new patient visits in the postperiod, especially in the no diabetes cohort. With this increase in new patient visits, CHCs saw an equivalent decrease in established patient visits. Yet, Ͼ70% of visits in the postperiod were established patient visits in the diabetes and prediabetes cohorts.
Results
Change in Rates of Payment Types by Diabetes Status and Expansion Status
Before ACA implementation, CHCs in expansion and nonexpansion states saw greater rates of uninsured visits among patient populations with diabetes and prediabetes than among those with no diabetes ( Table 2 ). The decline in uninsured visits after ACA implementation was significantly greater in expansion states, with a decrease of Ͼ50% compared with nonexpansion states with Ͻ20% change. CHCs saw similar drops in uninsured visit rates among all 3 cohorts (diabetes, prediabetes, and no diabetes).
The rate of Medicaid visits (Table 3) at CHCs in expansion states increased the most among the prediabetes cohort (RR, 1.71; 95% CI, 1.53-1.88), a 71% increase compared with an increase of 57% for the diabetes cohort (RR, 1.57; 95% CI, 1.43-1.71) and 60% for the no diabetes cohort (RR, 1.60; 95% CI, 1.46 -1.73). In nonexpansion states, the rate of privately insured visits more than tripled for the prediabetes cohort (RR, 3.17; 95% CI, 2.02-3.38) and more than doubled for the diabetes (RR, 2.77; 95% CI, 1.79 -375) and no diabetes (RR, 2.70; 95% CI, 2.02-3.38) cohorts; despite the large increases in privately insured visit rates from pre-ACA to post-ACA, the post-ACA rate of insured visits (private ϩ Medicaid insured) was lower in nonexpansion states than the insured visit rate in expansion states. 
Change in Rates of Visit Types by Diabetes Status and Expansion Status
In both expansion and nonexpansion states, CHCs' rates of total visits post-ACA were highest among the cohort with diabetes. Overall, the rates of total and primary care visits did not increase from pre-ACA to post-ACA in expansion and nonexpansion states for the diabetes or no diabetes cohorts. Among the prediabetes cohort, total and primary care visit rates at CHCs in expansion significantly increased by 15% (RR, 1.15; 95% CI, 1.09 -1.20) and 14% (RR, 1.14; 95% CI, 1.08 -1.19), respectively. The total visit rate also increased in nonexpansion states for the prediabetes cohort (RR, 1.10; 95% CI, 1.10 -1.19). After ACA implementation, preventive care visits for the prediabetes cohort increased 31% in expansion state CHCs (RR, 1.31; 95% CI, 1.19 -1.42) and 35% in nonexpansion state CHCs (RR, 1.35; 95% CI, 1.13-1.58). Among the prediabetes cohort in expansion states, rates for HbA1c screenings doubled (RR, 2.00; 95% CI, 1.80 -2.19) and rates for glucose testing increased by 23% (RR, 1.23; 95% CI, 1.17-1.30). Among the prediabetes cohort in nonexpansion states, HbA1c screenings increased 76% and glucose testing increased 24%. Among the cohort with diabetes, HbA1c tests increased less in expansion states than in nonexpansion state CHCs (26% vs 46%, respectively). Among the cohort with no diabetes, rates of screening for HbA1c and glucose testing increased in both expansion and nonexpansion state CHCs.
Conclusions
After ACA Medicaid expansion, rates of total and primary care visits did not change significantly for CHC patient populations with diabetes or those with no diabetes in expansion and nonexpansion states. Instead, CHCs experienced a shift in visit payer types (from uninsured to insured visits) rather than an increase in health care use. Patient populations with prediabetes saw a slight increase in total visit rates in both expansion (15%) and nonexpansion (14%) state CHCs.
Although total visit rates remained fairly stable, rates of insured CHC visits increased and rates of uninsured visits decreased among all 3 population cohorts included in this study in both expansion and nonexpansion state CHCs, which was reported previously for CHC patients. [12] [13] [14] [15] When comparing visit rates among the 3 population cohorts, those with diabetes had higher total visit rates (2.2/y) than those with prediabetes (1.9/y) or no diabetes (1.1/y). This total visit rate for those with diabetes is similar to national averages. 34 In expansion states, CHCs saw an increase in Medicaid-insured visits for all 3 population cohorts included in the study. Nonexpansion state CHCs had a surge in privately insured visits, especially among the populations of patients with diabetes and prediabetes. This change is likely due to (1) a shift in the type of visits from uninsured to privately insured due to the individual mandate, (2) motivated patients who obtained insurance to help manage existing health conditions, and (3) an influx of new patients with private insurance. Paradise et al 35 showed that CHCs are caring for a larger number of patients with private insurance post-ACA compared with pre-ACA because these patients experienced difficulties affording high deductibles and are in private plans with significant cost sharing. Han et al 36 highlighted increased funding for CHCs following the implementation of the ACA, which allowed CHCs to hire additional staff members and boost capacity for care. Indeed, the Uniform Data System (https://bphc.hrsa.gov) reports showed that the number of key staff members (eg, physicians, nurses, and physician assistants) have progressively increased to care for this influx of patients. Despite improvement, uninsured visit rates in nonexpansion states were higher post-ACA than in expansion states, suggesting that financial barriers may still exist for uninsured patients to acquire insurance coverage in nonexpansion states.
Contrary to our hypothesis, total visit rates for the population of patients with diabetes pre-ACA versus post-ACA were stable, which is likely due to the accessibility of care provided by CHCs. In addition to accessible care, CHCs provide high-quality care; they exceed Healthy People 2020 goals in various health outcomes, including diabetes control. 18 These findings reinforce the importance of CHCs for delivering care to vulnerable populations with chronic disease. Notably, even though the total number of visits for the population of patients with diabetes did not change, diabetes-specific screening rates increased, suggesting that insurance coverage had a positive impact on the receipt of timely preventive care.
The population of patients with prediabetes had an increase in total visit rates after ACA implemen-tation, and this prediabetes cohort also experienced the most sizable rise in rates of diabetes-specific screenings, especially in expansion state CHCs. The greatest change was observed for rates of HbA1c screenings, a critical preventive service for monitoring this population at risk of developing diabetes. 2 The significant increase in screening tests for the diabetes and prediabetes cohorts suggest that although uninsured patient populations were able to access visits pre-ACA, gaining insurance helped many of them access needed laboratory services post-ACA, which is consistent with previous findings in a much smaller subset of CHC patients. 22 Furthermore, the ACA included provisions that required all payers to fully cover many preventive services, including diabetes screening, and imposed strict limitations on cost sharing (eg, copayments and deductibles) for others. It is likely that these provisions benefited even CHC patient populations who had insurance pre-ACA by removing cost barriers to receiving preventive services, especially among those with high-deductible private insurance plans. 11 Because this provision was enacted before the study period, it likely did not impact our findings.
Proposals to "repeal and replace" the ACA suggest loosening or eliminating cost sharing limitations. 37 Yet, insurance plans with significant cost sharing and high out-of-pocket costs create critical access barriers to medical care, including specialty care and prescription medications essential for patients with chronic conditions. Under the ACA, low-income patients making Ͻ150% FPL can enroll in plans with significantly lower cost sharing. Thus, removing requirements for payers to cover preventive services and enabling payers to increase cost sharing for patients with diabetes or prediabetes could be harmful for access to needed preventive care.
This study has some limitations; it includes CHCs who are part of the ADVANCE network and, therefore, results may not be representative of all clinics, states, or expansion status groups. This analysis is visit based and does not assess the CHC population without visits. Although we adjusted for clinic panel and economic differences, unmeasured confounders, such as clinic-specific insurance outreach efforts, private insurance details (eg, deductibles and copayments), provider-patient communication, context and content of the visits, and citizenship status could impact our results. Patients who gained health insurance post-ACA may seek care outside CHCs; however, evidence suggests that most established CHC patients who gain coverage continue to receive care from CHCs. 38, 39 In addition, the present analysis did not assess whether the diabetes screenings were conducted as recommended. Future patient-level work is needed to assess whether the observed increase in HbA1c testing follows the recommended screening interval and eligibility. Some states (California, Washington, and Minnesota) expanded Medicaid eligibility early, which may attenuate the observed changes from pre-expansion to postexpansion states. Lastly, this analysis does not address changes in HbA1c or other patient outcomes. Future work should assess whether these changes improved patients' health outcomes.
In conclusion, CHCs do an excellent job of providing access to care for vulnerable populations. After implementation of the ACA, CHCs experienced a reduction in uninsured visit rates and an increase in Medicaid-insured visit rates, which has likely enabled them to provide more comprehensive services to their vulnerable patients. For example, the CHC population with prediabetes had increased rates of diabetes screenings after ACA implementation. The various different options to repeal, replace, under budget, or alter the ACA could lead to millions of low-income patients who gained coverage under the ACA to lose coverage, benefits, financial assistance, and/or consumer protection. Although the findings show that CHC populations, especially those with diabetes or prediabetes, receive health care services from CHCs regardless of health insurance status, they also show that gaining health insurance coverage after implementation of the ACA was associated with improved receipt of preventive services, which reduces health care expenditures and saves lives. 
